Insights

Filters
clear all
Filters
Topics
Industry
Type
Brand
Disability Article

Secrets to a Successful Stay At Work Program

7 MIN READ

A good stay-at-work program can offer many benefits to employees and employers, but establishing a successful plan can sometimes be a challenge. To help make this process easier, I'm joined by Genex experts Kevin Ufier and Linda Mastropaolo who will offer tips on how to develop a successful program.

Workers' Comp Blog

Investigating the Top Therapeutic Classes

2 MIN READ

First Script saw a decrease in opioid utilization across our retail and mail-order programs in 2018. In 2017, opioids made up 29.7% of total prescriptions, dropping to 26.9% in 2018, and representing a 2.8% decrease in utilization year over year.

Disability Article

Secrets to a Successful Stay At Work Program

7 MIN READ

A good stay-at-work program can offer many benefits to employees and employers, but establishing a successful plan can sometimes be a challenge. To help make this process easier, I'm joined by experts Kevin Ufier and Linda Mastropaolo who will offer tips on how to develop a successful program.

Workers' Comp Article

Opioids in 2019: Insights into New Regulations and Studies of the Epidemic

5 MIN READ

Momentum in battling the opioid crisis continues. As more states enact opioid prescribing limits, the federal government proposes new legislation, while new studies look at the impact of opioid laws and medical marijuana on lessening opioid abuse.

Workers' Comp Article

How Naloxone Can Help Fight the Opioid Crisis

3 MIN READ

As the U.S. looks for ways to stem the opioid crisis, one major strategy that has emerged is the use of naloxone to counteract opioid overdoses. The FDA’s recent approval of the generic form of Narcan®, which is the first generic formulation for naloxone nasal spray, provides another avenue to reverse the impact of the opioid crisis.

Workers' Comp Blog

Morphine Equivalent Dose (MED) Continues to Decline

3 MIN READ

In 2018 Coventry’s pharmacy benefit management solution, First Script®, saw a 7.8% decrease in average MED per prescription for its retail and mail-order channels. This was the largest decrease in the last 5 years across First Script’s retail and mail-order programs. In addition, there was a reduction in the percentage of opioid scripts with greater than or equal to 90 MED. To better understand why this is important let’s answer a few questions.

Mitchell Article

Humanizing the Collision Claims Experience in the Digital Age

Today’s customers have high expectations. From ordering coffee to online banking, they experience personalized, on-demand service from the businesses they interact with, and they expect the same from their insurers. How can insurance claims organizations adapt to a digital world and continue to exceed customer expectations? Start by reading these five tips from industry experts for humanizing the collision claims experience.

Media Coverage

See Why Enlyte Keeps Making Headlines

Read More
Media Kit

Access the Enlyte Media Kit

Media Kit